Table 1 Characteristics of the single-arm studies included in the review
Study author, year of publication [reference] | Country | Main parasite species | Drug schedule | Brand (manufacture) | Dosing | 28 day cure rate, n (%) | PCT | FCT |
|---|---|---|---|---|---|---|---|---|
Wang et al., 2003 [6] | China | P. falciparum | Single dosea | Co-NQ (KPC) | 8 Tabs (1000 mg ART + 400 mg NQ) | 97/100 (97) | 30 ± 8 | 17.5 ± 12.3 |
Nour et al., 2013 [10] | Sudan | P. falciparum | Single dose | ARCO (KPC) | 8 Tabs (1000 mg ART + 400 mg NQ) | 120/122 (98.4) | 34.8 ± 12.6 | 12 ± 4.8 |
Tun et al., 2009 [11] | Myanmar | P. falciparum | Single dose | ASNQ (KPC) | 52/53 (98.1) | 34.6 ± 14.3 | 18.2 ± 8.6 |